Capture and Disclose Spend Data in Compliance with State and Federal Requirements
- San Diego, California
As the industry anxiously awaits specific regulations from the government following the passage of the Sunshine Act within healthcare reform in March 2010, the focus on transparency and disclosure for medical device, biotech and pharmaceutical companies is at an all-time high. There are a number of state laws already on the books that require manufacturers to gather, aggregate, report and disclose financial payments to physicians practicing in those states. But, most challenging is the enterprise-wide collection of spend data related to your company’s interactions with physicians across the country required to be reported to the government in 2011 to meet the Sunshine provisions.
CBI’s Aggregate Spend Series has been addressing the challenges – and opportunities – related to state laws and aggregate spend reporting since 2007. With Sunshine requirements now upon us, CBI once again brings together government perspectives and industry thought leaders to discuss the most pressing issues related to aggregate spend tracking and reporting.
Once again, we take a closer look at the issues specifically affecting West Coast companies – including biotech and medical device manufacturers – for targeted, peer-to-peer strategies on implementing and improving spend tracking systems.
Topics being researched for the 2011 West Coast Forum include:
- Update on the federal Sunshine requirements and understanding of the state preemption clause
- Examination of recent and proposed state transparency and disclosure laws
- Ways to best achieve business accountability in the identification and capture of HCP and HCO data
- Collecting and verifying third-party vendor data
Lessons learned following the implementation of an aggregate spend solution
Earn CLE Credits! (Pending Approval)
Two Programs are offered at one convenient location to facilitate business exchange. Presentations are kept separate to ensure a focused learning experience, but opportunities for cross-functional collaboration are available throughout the two-day event.
For more information or to submit abstracts, please call Sharon Langan at 339-298-2115 or email her at Sharon.email@example.com